Stephen Maxted Ansell, MD, PhD

  • 20939 Citations
  • 77 Scopus h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1983 2019

2010
11 Citations (Scopus)
Chimerism
Melphalan
Hematologic Neoplasms
Tissue Donors
Survival
56 Citations (Scopus)

Comparison of error rates in single-arm versus randomized phase II cancer clinical trials

Tang, H., Foster, N. R., Grothey, A. F., Ansell, S. M., Goldberg, R. M. & Sargent, D. J., Apr 10 2010, In : Journal of Clinical Oncology. 28, 11, p. 1936-1941 6 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Randomized Controlled Trials
Patient Selection
Neoplasms
Statistical Models
103 Citations (Scopus)

Diagnosis and management of waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

Ansell, S. M., Kyle, R. A., Reeder, C. B., Fonseca, R., Mikhael, J. R., Morice, W. G., Bergsagel, P. L., Buadi, F. K., Colgan, J. P., Dingli, D. M., Dispenzieri, A., Greipp, P. R., Habermann, T. M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Lust, J. A., Markovic, S. N. & 13 others, Micallef, I., Nowakowski, G. S., Porrata, L. F., Roy, V., Russell, S. J., Detweiler Short, K. E., Stewart, A. K., Thompson, C. A., Witzig, T. E., Zeldenrust, S. R., Dalton, R. J., Rajkumar, S. V. & Gertz, M., 2010, In : Mayo Clinic Proceedings. 85, 9, p. 824-833 10 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Guidelines
Therapeutics
Immunoglobulin M
Plasmapheresis
28 Citations (Scopus)

Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma

Kelly, J. L., Novak, A. J., Fredericksen, Z. S., Liebow, M., Ansell, S. M., Dogan, A., Wang, A. H., Witzig, T. E., Call, T. G., Kay, N. E., Habermann, T. M., Slager, S. L. & Cerhan, J. R., Nov 2010, In : Cancer Epidemiology Biomarkers and Prevention. 19, 11, p. 2847-2858 12 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Apoptosis
Single Nucleotide Polymorphism
Genes
Genetic Translocation
6 Citations (Scopus)

Hematology: Trials and tribulations in primary CNS lymphoma

Ansell, S. M. & Rajkumar, S. V., Mar 2010, In : Nature Reviews Clinical Oncology. 7, 3, p. 125-126 2 p.

Research output: Contribution to journalArticle

Central Nervous System Neoplasms
Hematology
Antineoplastic Agents
Non-Hodgkin's Lymphoma
Lymphoma
51 Citations (Scopus)

IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Moreno Aspitia, A., Ansell, S. M., Kyle, R. & Mikhael, J. R., Nov 2010, In : American Journal of Hematology. 85, 11, p. 853-855 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Multiple Myeloma
Immunoglobulin M
Plasma Cells
Bone and Bones
34 Citations (Scopus)

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines

Wilcox, R. A., Sun, D. X., Novak, A. J., Dogan, A., Ansell, S. M. & Feldman, A. L., Jan 2010, In : Leukemia. 24, 1, p. 229-232 4 p.

Research output: Contribution to journalArticle

Intracellular Signaling Peptides and Proteins
T-Cell Lymphoma
Tumor Cell Line
Protein-Tyrosine Kinases
Non-Hodgkin's Lymphoma
15 Citations (Scopus)
Interleukin-15
Hematopoietic Stem Cell Transplantation
Peripheral Blood Stem Cell Transplantation
Natural Killer Cells
Non-Hodgkin's Lymphoma
40 Citations (Scopus)
Lymphopenia
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Recurrence
Drug Therapy
24 Citations (Scopus)
Peripheral Blood Stem Cell Transplantation
Lymphopenia
Lymphoma, Large B-Cell, Diffuse
Hematopoietic Stem Cell Transplantation
Lymphocyte Count
107 Citations (Scopus)

Phase II trial of the oral mammalian target of rapamycin inhibitor everolimus in relapsed or refractory waldenström macroglobulinemia

Ghobrial, I. M., Gertz, M., LaPlant, B., Camoriano, J. K., Hayman, S., Lacy, M., Chuma, S., Harris, B., Leduc, R., Rourke, M., Ansell, S. M., DeAngelo, D., Dispenzieri, A., Bergsagel, P. L., Reeder, C., Anderson, K. C., Richardson, P. G., Treon, S. P. & Witzig, T. E., Mar 10 2010, In : Journal of Clinical Oncology. 28, 8, p. 1408-1414 7 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Sirolimus
Disease-Free Survival
Everolimus
Phosphatidylinositol 3-Kinase
5 Citations (Scopus)

Phase i trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma

Litzow, M. R., Peethambaram, P. P., Safgren, S. L., Keeney, G., Ansell, S. M., Dispenzieri, A., Elliott, M. A., Gastineau, D. A., Gertz, M., Inwards, D. J., Lacy, M., Micallef, I., Porrata, L. F., Lingle, W. L., Hartmann, L. C., Frost, M. H., Barrette, B. A., Long, H. J., Suman, V. J., Reid, J. M. & 2 others, Ames, M. M. & Kaufmann, S. H., 2010, In : Bone Marrow Transplantation. 45, 3, p. 490-497 8 p.

Research output: Contribution to journalArticle

Topotecan
Carboplatin
Carcinoma
Disease-Free Survival
Type I DNA Topoisomerase
57 Citations (Scopus)

Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era

Nowakowski, G. S., Maurer, M. J., Habermann, T. M., Ansell, S. M., Macon, W. R., Ristow, K. M., Allmer, C., Slager, S. L., Witzig, T. E. & Cerhan, J. R., Jan 20 2010, In : Journal of Clinical Oncology. 28, 3, p. 412-417 6 p.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Rituximab
Disease-Free Survival
150 Citations (Scopus)

Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma

Drake, M. M., Maurer, M. J., Link, B. K., Habermann, T. M., Ansell, S. M., Micallef, I., Kelly, J. L., Macon, W. R., Nowakowski, G. S., Inwards, D. J., Johnston, P. B., Singh, R. J., Allmer, C., Slager, S. L., Weiner, G. J., Witzig, T. E. & Cerhan, J. R., Sep 20 2010, In : Journal of Clinical Oncology. 28, 27, p. 4191-4198 8 p.

Research output: Contribution to journalArticle

Vitamin D
Non-Hodgkin's Lymphoma
Disease-Free Survival
T-Cell Lymphoma
Survival
2009
38 Citations (Scopus)
Phosphatidylinositol 3-Kinase
Follicular Lymphoma
Cyclin D1
Cell proliferation
Sirolimus
122 Citations (Scopus)

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

Wilcox, R. A., Feldman, A. L., Wada, D. A., Yang, Z. Z., Comfere, N. I., Dong, H. M., Kwon, E. D., Novak, A. J., Markovic, S. N., Pittelkow, M. R., Witzig, T. E. & Ansell, S. M., 2009, In : Blood. 114, 10, p. 2149-2158 10 p.

Research output: Contribution to journalArticle

T-cells
Lymphoproliferative Disorders
Non-Hodgkin's Lymphoma
Tumor Microenvironment
Immunity

Biologic therapies for non-hodgkin lymphoma and hodgkin disease

Ansell, S. M., Jan 1 2009, Emerging Protein Biotherapeutics. CRC Press, p. 223-245 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Biological Therapy
Hodgkin Disease
Non-Hodgkin's Lymphoma
Cells
Monoclonal Antibodies
10 Citations (Scopus)

Cytokines in the microenvironment of Waldenström's macroglobulinemia

Elsawa, S. & Ansell, S. M., 2009, In : Clinical Lymphoma and Myeloma. 9, 1, p. 43-45 3 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytokines
Immunoglobulins
Tumor Microenvironment
Growth
48 Citations (Scopus)

Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma

Novak, A. J., Slager, S. L., Fredericksen, Z. S., Wang, A. H., Manske, M. M., Ziesmer, S., Liebow, M., Macon, W. R., Dillon, S. R., Witzig, T. E., Cerhan, J. R. & Ansell, S. M., May 15 2009, In : Cancer Research. 69, 10, p. 4217-4224 8 p.

Research output: Contribution to journalArticle

B-Cell Activating Factor
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Alleles
121 Citations (Scopus)
Histone Deacetylases
Lymphoma, Large B-Cell, Diffuse
Sirolimus
Cells
Histone Deacetylase Inhibitors
180 Citations (Scopus)

Intraepithelial Effector (CD3+)/Regulatory (FoxP3+) T-Cell Ratio Predicts a Clinical Outcome of Human Colon Carcinoma

Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R. & Sargent, D. J., Oct 2009, In : Gastroenterology. 137, 4, p. 1270-1279 10 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Colon
Carcinoma
T-Lymphocytes
Disease-Free Survival
110 Citations (Scopus)

Malignant B cells skew the balance of regulatory T cells and T H17 cells in B-cell non-Hodgkin's lymphoma

Yang, Z. Z., Novak, A. J., Ziesmer, S. C., Witzig, T. E. & Ansell, S. M., Jul 1 2009, In : Cancer Research. 69, 13, p. 5522-5530 9 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Regulatory T-Lymphocytes
Interleukin-17
Non-Hodgkin's Lymphoma
Interleukin-2
97 Citations (Scopus)

Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

Wilcox, R. A., Wada, D. A., Ziesmer, S. C., Elsawa, S. F., Comfere, N. I., Dietz, A. B., Novak, A. J., Witzig, T. E., Feldman, A. L., Pittelkow, M. R. & Ansell, S. M., 2009, In : Blood. 114, 14, p. 2936-2944 9 p.

Research output: Contribution to journalArticle

T-cells
Lymphoproliferative Disorders
Dendritic Cells
Tumors
Monocytes
194 Citations (Scopus)

Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

Ansell, S. M., Hurvitz, S. A., Koenig, P. A., LaPlant, B. R., Kabat, B. F., Fernando, D., Habermann, T. M., Inwards, D. J., Verma, M., Yamada, R., Erlichman, C., Lowy, I. & Timmerman, J. M., Oct 15 2009, In : Clinical Cancer Research. 15, 20, p. 6446-6453 8 p.

Research output: Contribution to journalArticle

CTLA-4 Antigen
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
T-Lymphocytes
10 Citations (Scopus)

Risk of non-Hodgkin lymphoma in association with germline variation in complement genes

Cerhan, J. R., Novak, A. J., Fredericksen, Z. S., Wang, A. H., Liebow, M., Call, T. G., Dogan, A., Witzig, T. E., Ansell, S. M., Habermann, T. M., Kay, N. E. & Slager, S. L., Jun 2009, In : British Journal of Haematology. 145, 5, p. 614-623 10 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Single Nucleotide Polymorphism
Genes
Haplotypes
Principal Component Analysis
15 Citations (Scopus)

Serum BLyS levels increase after rituximab as initial therapy in patients with follicular grade 1 non-Hodgkin lymphoma

Ansell, S. M., Novak, A. J., Ziesmer, S., Price-Troska, T., Laplant, B., Dillon, S. R. & Witzig, T. E., Feb 2009, In : American Journal of Hematology. 84, 2, p. 71-73 3 p.

Research output: Contribution to journalArticle

B-Cell Activating Factor
Non-Hodgkin's Lymphoma
Serum
Therapeutics
B-Lymphocytes
15 Citations (Scopus)

The role of Treg cells in the cancer immunological response

Yang, Z. Z. & Ansell, S. M., 2009, In : American Journal of Immunology. 5, 1, p. 17-28 12 p.

Research output: Contribution to journalArticle

Regulatory T-Lymphocytes
Neoplasms
Immunity
Allergy and Immunology
T-Lymphocytes
2008
112 Citations (Scopus)

A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma

Racila, E., Link, B. K., Weng, W. K., Witzig, T. E., Ansell, S. M., Maurer, M. J., Huang, J., Dahle, C., Halwani, A., Levy, R. & Werner, G. J., Oct 15 2008, In : Clinical Cancer Research. 14, 20, p. 6697-6703 7 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Therapeutics
Alleles
Monoclonal Antibodies
Confidence Intervals
16 Citations (Scopus)

A role for IFN-λ1 in multiple myeloma B cell growth

Novak, A. J., Grote, D. M., Ziesmer, S. C., Rajkumar, S. V., Doyle, S. E. & Ansell, S. M., 2008, In : Leukemia. 22, 12, p. 2240-2246 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Interferons
B-Lymphocytes
Growth
Cytokines
70 Citations (Scopus)

Autologous stem cell transplant in 716 patients with multiple myeloma: Low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative

Gertz, M., Ansell, S. M., Dingli, D. M., Dispenzieri, A., Buadi, F. K., Elliott, M. A., Gastineau, D. A., Hayman, S. R., Hogan, W., Inwards, D. J., Johnston, P. B., Kumar, S. K., Lacy, M., Leung, N., Micallef, I., Porrata, L. F., Schafer, B. A., Wolf, R. C. & Litzow, M. R., 2008, In : Mayo Clinic Proceedings. 83, 10, p. 1131-1135 5 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Outpatients
Stem Cells
Transplants
Mortality
5 Citations (Scopus)

CDDO-imidazolide mediated inhibition of malignant cell growth in Waldenström macroglobulinemia

Elsawa, S. F., Novak, A. J., Grote, D., Konopleva, M., Andreeff, M., Witzig, T. E. & Ansell, S. M., Dec 2008, In : Leukemia Research. 32, 12, p. 1895-1902 8 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Growth
B-Lymphocytes
Cell Death
Neoplasms
97 Citations (Scopus)

Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Gastineau, D. A., Litzow, M. R., Winters, J. L. & Markovic, S. N., Jul 2008, In : Biology of Blood and Marrow Transplantation. 14, 7, p. 807-816 10 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Prospective Studies
Lymphocytes
Confidence Intervals
15 Citations (Scopus)
Mucositis
Melphalan
Lymphoma, Large B-Cell, Diffuse
Hematopoietic Stem Cell Transplantation
Body Weight
60 Citations (Scopus)

Genetic variation in tumor necrosis factor and the nuclear factor-κB canonical pathway and risk of non-Hodgkin's lymphoma

Cerhan, J. R., Liu-Mares, W., Fredericksen, Z. S., Novak, A. J., Cunningham, J. M., Kay, N. E., Dogan, A., Liebow, M., Wang, A. H., Call, T. G., Habermann, T. M., Ansell, S. M. & Slager, S. L., Nov 2008, In : Cancer Epidemiology Biomarkers and Prevention. 17, 11, p. 3161-3169 9 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Tumor Necrosis Factor-alpha
Single Nucleotide Polymorphism
Genes
Odds Ratio
19 Citations (Scopus)
Germinal Center
Lymphoma, Large B-Cell, Diffuse
Hematopoietic Stem Cell Transplantation
B-Lymphocytes
Hematopoietic Stem Cells
18 Citations (Scopus)

High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system

Gill, P., Litzow, M. R., Buckner, J. C., Arndt, C. A. S., Moynihan, T., Christianson, T., Ansell, S. M. & Galanis, E., Apr 15 2008, In : Cancer. 112, 8, p. 1805-1811 7 p.

Research output: Contribution to journalArticle

Central Nervous System Neoplasms
Stem Cell Transplantation
Drug Therapy
Disease Progression
Survival
58 Citations (Scopus)

Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era

Habermann, T. M., Wang, S. S., Maurer, M. J., Morton, L. M., Lynch, C. F., Ansell, S. M., Hartge, P., Severson, R. K., Rothman, N., Davis, S., Geyer, S. M., Cozen, W., Chanock, S. J. & Cerhan, J. R., Oct 1 2008, In : Blood. 112, 7, p. 2694-2702 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Polymorphism
Hazards
Genes
Cells
17 Citations (Scopus)

Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: Analysis after a minimum follow-up of 5 years

Malhotra, P., Hogan, W., Litzow, M. R., Elliott, M. A., Gastineau, D. A., Ansell, S. M., Dispenzieri, A., Gertz, M., Hayman, S. R., Inwards, D. J., Lacy, M., Micallef, I., Porrata, L. F. & Tefferi, A., 2008, In : Leukemia and Lymphoma. 49, 9, p. 1724-1730 7 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
B-Cell Chronic Lymphocytic Leukemia
Transplants
Graft vs Host Disease
Salvage Therapy
58 Citations (Scopus)

Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central Cancer Treatment Group

Inwards, D. J., Fishkin, P. A. S., Hillman, D. W., Brown, D. W., Ansell, S. M., Kurtin, P. J., Fonseca, R., Morton, R. F., Veeder, M. H. & Witzig, T. E., Jul 1 2008, In : Cancer. 113, 1, p. 108-116 9 p.

Research output: Contribution to journalArticle

Cladribine
Mantle-Cell Lymphoma
Neoplasms
Therapeutics
Rituximab
177 Citations (Scopus)

Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: A phase 2 trial in the North Central Cancer Treatment Group

Ansell, S. M., Inwards, D. J., Rowland, K. M., Flynn, P. J., Morton, R. F., Moore, D. F., Kaufmann, S. H., Ghobrial, I., Kurtin, P. J., Maurer, M., Allmer, C. & Witzig, T. E., Aug 1 2008, In : Cancer. 113, 3, p. 508-514 7 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Neoplasms
Therapeutics
temsirolimus
Confidence Intervals
88 Citations (Scopus)

Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome

Dispenzieri, A., Lacy, M., Hayman, S. R., Kumar, S. K., Buadi, F., Dingli, D. M., Litzow, M. R., Gastineau, D. A., Inwards, D. J., Elliott, M. A., Micallef, I., Ansell, S. M., Hogan, W., Porrata, L. F., Johnston, P. B., Afessa, B., Bryce, A. H., Kyle, R. A. & Gertz, M., May 2008, In : European Journal of Haematology. 80, 5, p. 397-406 10 p.

Research output: Contribution to journalArticle

POEMS Syndrome
Peripheral Blood Stem Cell Transplantation
Transplants
Vascular Endothelial Growth Factor A
Thrombocytosis
35 Citations (Scopus)

Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma

Ansell, S. M., Witzig, T. E., Inwards, D. J., Porrata, L. F., Ythier, A., Ferrande, L., Nestorov, I., DeVries, T., Dillon, S. R., Hausman, D. & Novak, A. J., Feb 15 2008, In : Clinical Cancer Research. 14, 4, p. 1105-1110 6 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
B-Cell Activating Factor
Immunoglobulins
B-Lymphocytes

Preface

Ansell, S. M., 2008, In : Unknown Journal.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Rare hematological malignancies

Ansell, S. M. & Rosen, S. T., 2008, Springer US. 433 p.

Research output: Book/ReportBook

Hematologic Neoplasms
Physicians
Hematologic Diseases
Primary Care Physicians
Disease Management
Lymphocyte Count
Radio
Immunotherapy
Lymphoma
Therapeutics

The use of cell lines for the study of Waldenström's macroglobulinemia

Gertz, M. & Ansell, S. M., Nov 2008, In : Leukemia Research. 32, 11, p. 1648-1649 2 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cell Line
Leukemia
Research
38 Citations (Scopus)

The value of [18f]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma

Karantanis, D., Subramaniam, R. M., Peller, P. J., Lowe, V., Durski, J. M., Collins, D. A., Georgiou, E., Ansell, S. M. & Wiseman, G. A., Apr 2008, In : Clinical Lymphoma and Myeloma. 8, 2, p. 94-99 6 p.

Research output: Contribution to journalArticle

Natural Killer T-Cells
T-Cell Lymphoma
Fluorodeoxyglucose F18
Paranasal Sinuses
Nasopharyngeal Diseases
16 Citations (Scopus)
Stem Cell Transplantation
Recurrence
Survival
Therapeutics
Investigational Therapies

Wnt-erizing mantle cell lymphoma

Ansell, S. M., Dec 15 2008, In : Blood. 112, 13, p. 4783-4784 2 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
2007
18 Citations (Scopus)

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas [9]

Porrata, L. F., Ristow, K., Witzig, T. E., Tuinistra, N., Habermann, T. M., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B. & Markovic, S. N., Dec 2007, In : Leukemia. 21, 12, p. 2554-2556 3 p.

Research output: Contribution to journalArticle

Yttrium Radioisotopes
Neoplasm Drug Resistance
Radioimmunotherapy
Salvage Therapy
Follicular Lymphoma